Cagrilintide

Amylin analog

A rising amylin-analog weight-loss compound that matters most in combination and comparison conversations.

EVIDENCEEmerging

DELIVERYInjection

PRICE RANGE—

PRODUCTS0 Verified

ARTICLES0 Published

How It Works

Cagrilintide mimics amylin signaling to support appetite suppression through a pathway distinct from GLP-1-based compounds.

injection

Cagrilintide is mostly discussed as an injectable appetite-support compound, often in comparison or combination planning next to semaglutide.

Trial and combination-product discussions usually frame cagrilintide as once-weekly subcutaneous use.

Weight-loss and appetite-response expectations are usually framed over multi-week titration windows rather than immediate changes.